These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27487100)

  • 1. Are we ready for precision medicine in acute myeloid leukemia?
    Roboz GJ
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):582-4. PubMed ID: 27487100
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.
    Kadia TM; Ravandi F; Cortes J; Kantarjian H
    JAMA Oncol; 2015 Sep; 1(6):820-8. PubMed ID: 26181162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I treat the older patient with acute myeloid leukemia.
    Ossenkoppele G; Löwenberg B
    Blood; 2015 Jan; 125(5):767-74. PubMed ID: 25515963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.
    Heuser M; Mina A; Stein EM; Altman JK
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():411-420. PubMed ID: 31099617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
    Schlenk RF; Döhner K; Döhner H
    Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision therapy for acute myeloid leukemia.
    Yang X; Wang J
    J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
    Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
    Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfavorable-risk acute myeloid leukemia dissected.
    Strickland SA; Mohan SR; Savona MR
    Curr Opin Hematol; 2016 Mar; 23(2):144-9. PubMed ID: 26825699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving toward targeted therapies in acute myeloid leukemia.
    Gao W; Estey E
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 11. Precision medicine in acute myeloid leukemia: Hope, hype or both?
    Prasad V; Gale RP
    Leuk Res; 2016 Sep; 48():73-7. PubMed ID: 27497757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
    Boissel N; Nibourel O; Renneville A; Huchette P; Dombret H; Preudhomme C
    Blood; 2011 Mar; 117(13):3696-7. PubMed ID: 21454467
    [No Abstract]   [Full Text] [Related]  

  • 13. Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.
    Reville PK; Kadia T
    Curr Treat Options Oncol; 2020 Apr; 21(4):34. PubMed ID: 32318829
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sadigh S; Morrissette JJD; Bagg A
    Leuk Lymphoma; 2019 Jun; 60(6):1601-1602. PubMed ID: 30632836
    [No Abstract]   [Full Text] [Related]  

  • 15. The road to precision oncology.
    Biankin AV
    Nat Genet; 2017 Feb; 49(3):320-321. PubMed ID: 28232728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk-adapted therapy in acute myeloid leukemia].
    Fiegl M; Hiddemann W
    Internist (Berl); 2012 Apr; 53(4):392, 394-9. PubMed ID: 22410942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mutations in acute myeloid leukemia that influence clinical decisions.
    Chung SS
    Curr Opin Hematol; 2014 Mar; 21(2):87-94. PubMed ID: 24445361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New clinical evidence and drugs].
    Kobayashi Y
    Rinsho Ketsueki; 2013 Oct; 54(10):1660-70. PubMed ID: 24064815
    [No Abstract]   [Full Text] [Related]  

  • 20. Personalised vaccine against acute myeloid leukaemia.
    Burki TK
    Lancet Oncol; 2017 Jan; 18(1):e7. PubMed ID: 27989431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.